AAAAAA
Results:
1-15
|
Results: 15
Authors:
GURUNATHAN S
IRVINE KR
WU CY
COHEN JI
THOMAS E
PRUSSIN C
RESTIFO NP
SEDER RA
Citation: S. Gurunathan et al., CD40 LIGAND TRIMER DNA ENHANCES BOTH HUMORAL AND CELLULAR IMMUNE-RESPONSES AND INDUCES PROTECTIVE IMMUNITY TO INFECTIOUS AND TUMOR CHALLENGE/, The Journal of immunology (1950), 161(9), 1998, pp. 4563-4571
Authors:
SURMAN DR
IRVINE KR
SHULMAN EP
ALLWEIS TM
ROSENBERG SA
RESTIFO NP
Citation: Dr. Surman et al., GENERATION OF POLYCLONAL RABBIT ANTISERA TO MOUSE MELANOMA-ASSOCIATEDANTIGENS USING GENE GUN IMMUNIZATION, Journal of immunological methods, 214(1-2), 1998, pp. 51-62
Authors:
PORGADOR A
IRVINE KR
IWASAKI A
BARBER BH
RESTIFO NP
GERMAIN RN
Citation: A. Porgador et al., PREDOMINANT ROLE FOR DIRECTLY TRANSFECTED DENDRITIC CELLS IN ANTIGEN PRESENTATION TO CD8(+)T CELLS AFTER GENE GUN IMMUNIZATION, The Journal of experimental medicine, 188(6), 1998, pp. 1075-1082
Authors:
OVERWIJK WW
TSUNG A
IRVINE KR
PARKHURST MR
GOLETZ TJ
TSUNG K
CARROLL MW
LIU CL
MOSS B
ROSENBERG SA
RESTIFO NP
Citation: Ww. Overwijk et al., GP100 PMEL-17 IS A MURINE TUMOR REJECTION ANTIGEN - INDUCTION OF SELF-REACTIVE, TUMORICIDAL T-CELLS USING HIGH-AFFINITY, ALTERED PEPTIDE LIGAND/, The Journal of experimental medicine, 188(2), 1998, pp. 277-286
Authors:
IRVINE KR
CHAMBERLAIN RS
SHULMAN EP
ROSENBERG SA
RESTIFO NP
Citation: Kr. Irvine et al., ROUTE OF IMMUNIZATION AND THE THERAPEUTIC IMPACT OF RECOMBINANT ANTICANCER VACCINES, Journal of the National Cancer Institute, 89(5), 1997, pp. 390-392
Authors:
IRVINE KR
CHAMBERLAIN RS
SHULMAN EP
SURMAN DR
ROSENBERG SA
RESTIFO NP
Citation: Kr. Irvine et al., ENHANCING EFFICACY OF RECOMBINANT ANTICANCER VACCINES WITH PRIME BOOST REGIMENS THAT USE 2 DIFFERENT VECTORS/, Journal of the National Cancer Institute, 89(21), 1997, pp. 1595-1601
Authors:
IRVINE KR
CHAMBERLAIN RS
BRONTE V
ROSENBERG SA
RESTIFO NP
Citation: Kr. Irvine et al., THE ROUTE OF ADMINISTRATION OF RECOMBINANT VACCINIA VIRUS (RVV) VACCINES EFFECTS THE ACTIVE TREATMENT OF CANCER, The FASEB journal, 10(6), 1996, pp. 2711-2711
Authors:
RAO JB
CHAMBERLAIN RS
BRONTE V
CARROLL MW
IRVINE KR
MOSS B
ROSENBERG SA
RESTIFO NP
Citation: Jb. Rao et al., IL-12 IS AN EFFECTIVE ADJUVANT TO RECOMBINANT VACCINIA VIRUS-BASED TUMOR VACCINES - ENHANCEMENT BY SIMULTANEOUS B7-1 EXPRESSION, The Journal of immunology, 156(9), 1996, pp. 3357-3365
Authors:
IRVINE KR
RAO JB
ROSENBERG SA
RESTIFO NP
Citation: Kr. Irvine et al., CYTOKINE ENHANCEMENT OF DNA IMMUNIZATION LEADS TO EFFECTIVE TREATMENTOF ESTABLISHED PULMONARY METASTASES, The Journal of immunology, 156(1), 1996, pp. 238-245
Authors:
IRVINE KR
RESTIFO NP
Citation: Kr. Irvine et Np. Restifo, THE NEXT WAVE OF RECOMBINANT AND SYNTHETIC ANTICANCER VACCINES, Seminars in cancer biology, 6(6), 1995, pp. 337-347
Authors:
IRVINE KR
MCFARLAND BJ
ROSENBERG SA
RESTIFO NP
Citation: Kr. Irvine et al., SYNTHETIC OLIGONUCLEOTIDE EXPRESSED BY RECOMBINANT VACCINIA VIRUS ELICITS THERAPEUTIC CYTOLYTIC T-LYMPHOCYTES, The FASEB journal, 9(3), 1995, pp. 494-494
Authors:
RESTIFO NP
BACIK I
IRVINE KR
YEWDELL JW
MCCABE BJ
ANDERSON RW
EISENLOHR LC
ROSENBERG SA
BENNINK JR
Citation: Np. Restifo et al., ANTIGEN-PROCESSING IN-VIVO AND THE ELICITATION OF PRIMARY CTL RESPONSES, The Journal of immunology, 154(9), 1995, pp. 4414-4422
Authors:
IRVINE KR
MCCABE BJ
ROSENBERG SA
RESTIFO NP
Citation: Kr. Irvine et al., SYNTHETIC OLIGONUCLEOTIDE EXPRESSED BY A RECOMBINANT VACCINIA VIRUS ELICITS THERAPEUTIC CTL, The Journal of immunology, 154(9), 1995, pp. 4651-4657
Authors:
MCCABE BJ
IRVINE KR
NISHIMURA MI
YANG JC
SPIESS PJ
SHULMAN EP
ROSENBERG SA
RESTIFO NP
Citation: Bj. Mccabe et al., MINIMAL DETERMINANT EXPRESSED BY A RECOMBINANT VACCINIA VIRUS ELICITSTHERAPEUTIC ANTITUMOR CYTOLYTIC T-LYMPHOCYTE RESPONSES, Cancer research, 55(8), 1995, pp. 1741-1747
Authors:
RESTIFO NP
MINEV BR
TAGGARSE AS
MCFARLAND BJ
WANG M
IRVINE KR
Citation: Np. Restifo et al., ENHANCING THE RECOGNITION OF TUMOR-ASSOCIATED ANTIGENS, Folia biologica, 40(1-2), 1994, pp. 74-88
Risultati:
1-15
|